type sequence filename description text html head head body bgcolor ffffff link blue vlink purple style font family time roman align right style margin text align right font size face time roman style font size font weight bold exhibit nbsp font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size certain material indicated asterisk been omitted from this document pursuant request confidential treatment nbsp omitted material been filed separately with security exchange commission font style margin font size face time roman style font size nbsp font align right style margin text align right font size face time roman style font size execution copy font style margin font size face time roman style font size nbsp font style font weight bold margin text align center font size face time roman style font size supplemental agreement font align center style margin text align center font size face time roman style font size font weight bold license research collaboration agreement font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size this supplemental agreement nbsp supplement nbsp license research collaboration agreement dated november nbsp license agreement entered into nbsp supplement effective date between selecta bioscience nbsp selecta sanofi sanofi selecta sanofi shall individually referred party collectively party font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold recital font style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font weight bold whereas font pursuant section nbsp license agreement selecta granted sanofi sanofi option whereby sanofi right acquire exclusive even selecta license territory under selecta licensed technology including right grant sublicenses through multiple tier optional indication term indication forth section nbsp license agreement style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font weight bold whereas font november nbsp sanofi delivered selecta notice exercise related second indication november nbsp selecta sent notice sanofi indicating that would like grant sanofi expanded license optional indication style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font weight bold whereas font party agree that certain term license agreement including limited second payment appropriate second indication therefore need amended second indication style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font weight bold therefore font consideration mutual covenant herein contained other good valuable consideration receipt sufficiency which hereby acknowledged party agree follows style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font weight bold font style font weight bold capitalized term capitalized term defined herein shall have meaning ascribed them license agreement style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font weight bold font celiac disease shall mean inflammation other adverse immune reaction caused gluten style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font weight bold font second indication shall mean optional indication celiac disease which sanofi successfully exercised right under section nbsp license agreement style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font weight bold font style font weight bold amendment this supplement nbsp shall deemed amendment purpose interpreting section nbsp license agreement party further agree that execution this supplement nbsp shall deemed satisfy requirement section nbsp license agreement that party enter into amendment within after selecta agreed work second indication unless otherwise specified herein term condition license agreement applicable initial indication shall also apply second indication style margin font size face time roman style font size nbsp font style margin font size face time roman style font size certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion font style margin font size face time roman style font size nbsp font style margin size width noshade align left style color selecta biosiences folio file disk _zcv user hyung clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font weight bold font style font weight bold celiac disease indication party agree that upon execution this supplement celiac disease shall deemed indication purpose interpreting license agreement furtherance thereof party agree that first sentence section nbsp license agreement shall deemed have been replaced entirety following sentence style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font style italic indication mean nbsp initial indication nbsp second indication font style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font weight bold font style font weight bold financial obligation style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font weight bold font first payment selecta shall submit invoice sanofi execution this suppplement nbsp soon possible thereafter first payment equal million dollar expanded license second indication sanofi shall such invoice within business after receipt style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font weight bold font second payment party hereby agree that second payment second indication shall replaced entirety following three payment with understanding that payment second indication shall subject article nbsp payment report license agreement style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font upon style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font upon style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font upon style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font weight bold font development milestone subject subsection nbsp above sanofi shall selecta development milestone amount related achievement development milestone forth section nbsp nbsp license agreement second indication would initial indication style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font weight bold font sale milestone royalty sanofi shall selecta sale milestone forth section nbsp nbsp license agreement royalty payment forth section nbsp license agreement licensed product second indication would initial indication each case licensed product licensed product basis subject relevant reduction license agreement including limited those reduction forth section nbsp style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font weight bold font style font weight bold development candidate research plan committee party agree that each indication shall have development candidate development candidate nomination criterion research plan joint research committee joint manufacturing committee therefore reference development candidate development candidate nomination criterion research plan joint research committee joint manufacturing committee shall interpreted mean development candidate development candidate nomination criterion research plan joint research committee joint manufacturing committee applicable such indication purpose clarity while shall specific each indication style margin font size face time roman style font size nbsp font style margin font size face time roman style font size certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion font style margin font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color selecta biosiences folio file disk _zcv user hyung clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size person such committee initial indication also such committee second indication party further agree that alliance manager shall same both indication reference license agreement initial research plan with respect second indication shall mean research plan attached hereto exhibit nbsp attached hereto exhibit nbsp development candidate nomination criterion second indication font style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font weight bold font style font weight bold research term other date except otherwise stated herein with regard second indication date license agreement that referential effective date shall deemed referential supplemental effective date example section nbsp license agreement research plan second indication shall reviewed approved each year anniversary supplement effective date party further agree that research term second indication will continue period year unless development candidate nomination second indication occurred earlier therefore under section nbsp license agreement research term second indication will deemed commence supplement effective date will continue until earlier nbsp nbsp anniversary supplemental effective date unless extended forth section nbsp license agreement style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font weight bold font style font weight bold option extend field party agree that upon execution this supplement granting expanded license second indication sanofi shall longer have right exercise sanofi option other optional indication style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font weight bold font style font weight bold effort sanofi first sentence section nbsp license agreement shall deemed have been replaced entirety following sentence style margin font size face time roman style font size nbsp font style font size margin font size face time roman style font size font style italic subject this section nbsp sanofi shall commercially reasonable effort research develop commercialize least licensed product each initial indication second indication nbsp font nbsp nbsp nbsp style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font weight bold font style font weight bold press release notwithstanding anything contrary contained section nbsp license agreement selecta issue press release attached exhibit nbsp hereto anytime within business supplement effective date style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font weight bold font style font weight bold effect agreement except provided this supplement nbsp other term license agreement shall remain full force effect unaffected this supplement nbsp style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font weight bold font style font weight bold construction except where context otherwise requires wherever used singular shall include plural plural singular gender shall applicable gender language part this amendment nbsp shall deemed language mutually chosen party party their counsel have cooperated drafting preparation this amendment nbsp this amendment nbsp therefore shall construed against party virtue role drafter thereof style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font weight bold font style font weight bold counterpart this supplement nbsp executed party multiple counterpart each which shall deemed original which taken together shall style margin font size face time roman style font size nbsp font style margin font size face time roman style font size certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion font style margin font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color selecta biosiences folio file disk _zcv user hyung clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size constitute same instrument this amendment nbsp executed facsimile signature such signature shall deemed bind each party hereto they were original signature font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font style italic signature page nbsp follows font style margin font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color selecta biosiences folio file disk _zcv user hyung clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font weight bold witness whereof font party hereto have caused this supplement nbsp license agreement executed their respective duly authorized officer supplement effective date style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width colspan valign style padding width style margin text indent font size face time roman style font size selecta therapeutic nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size sanofi font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size font width valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size werner cautreels font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size font width valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size constantine chinoporos font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size name font width valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size werner cautreels font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size name font width valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size constantine chinoporos font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size title font width valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size president font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size title font width valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size vice president font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size date font width valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size date font width valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size font table style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font style italic signature page supplement agreement font align center style margin text align center font size face time roman style font size font style italic nbsp font style margin size width noshade align left style color selecta biosiences folio file disk _zcv user hyung style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold exhibit nbsp formulation criterion font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size formulation manufactured characterized selecta shall meet following specification criterion based selecta characterization provided that such characterization shall sufficiently consistent across batch enable vivo testing font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion font style margin font size face time roman style font size nbsp font style margin size width noshade align left style color selecta biosiences folio file disk _zcv user hyung clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style font size margin font size face time roman style font size font weight bold exhibit nbsp font research plan style margin font size face time roman style font size nbsp font style margin font size face time roman style font size selecta scope work until declaration font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size sanofi scope work until declaration font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion font style margin font size face time roman style font size nbsp font style margin size width noshade align left style color selecta biosiences folio file disk _zcv user hyung clear style page break before always style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold exhibit nbsp development candidate nomination criterion font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size development candidate nomination criterion font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion font style margin font size face time roman style font size nbsp font style margin size width noshade align left style color selecta biosiences folio file disk _zcv user hyung clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold exhibit nbsp press release font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold sanofi exercise option second therapeutic program with selecta bioscience develop antigen specific immunotherapy based synthetic vaccine particle technology font style margin font size face time roman style font size nbsp font style font size margin text indent font size face symbol style font size font font size style font size font celiac disease program added alliance addressing immune disorder related food airborne allergen style margin font size face time roman style font size nbsp font style font size margin text indent font size face symbol style font size font font size style font size font selecta eligible receive payment totaling million well double digit tiered royalty product sale immune tolerance product each program under alliance style margin font size face time roman style font size nbsp font style font size margin font size face time roman style font size font weight bold watertown mass nbsp font selecta bioscience nbsp clinical stage biotechnology company developing novel class targeted antigen specific immune therapy today announced that under term existing strategic global collaboration sanofi euronext nyse exercised option exclusive license develop immunotherapy treatment celiac disease celiac disease patient consumption gluten containing food induces harmful immune response that lead abdominal pain most severe case intestinal cancer this immune tolerance program expands activity within sanofi selecta collaboration which already successfully advancing novel immunotherapy life threatening food allergy product resulting from this collaboration will leverage selecta proprietary synthetic vaccine particle svptm platform which unique capability engineer nanoparticles with structure composition produce immune tolerance attenuating overactive response specific antigen style margin font size face time roman style font size nbsp font style margin font size face time roman style font size sanofi selecta working together push toward outer barrier immunotherapy deliver innovative solution patient this area constantly evolving with partner like selecta breakthrough medicine within grasp said kurt stoeckli vice president head biotherapeutics research nbsp development sanofi font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size under term collaboration selecta eligible receive research support several clinical clinical regulatory sale milestone totaling million this program celiac disease additionally selecta also entitled double digit tiered royalty percentage product sale commercialized immunotherapy resulting from these effort with sanofi font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size very pleased that sanofi selecta collaborating three program immune tolerance said werner cautreels selecta president both sanofi selecta recognize tremendous unmet medical need addressing adverse immune response leading allergy autoimmune disease font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size november nbsp selecta announced that they formed strategic global collaboration discover highly targeted antigen specific immunotherapy life threatening allergy under agreement sanofi obtained first exclusive license develop immunotherapy designed abate acute immune response against life threatening food allergen option develop additional candidate immunotherapy allergy celiac disease with exercise this option sanofi selecta sanofi have initiative actively advancing immune font style margin font size face time roman style font size nbsp font style margin size width noshade align left style color selecta biosiences folio file disk _zcv user hyung clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size tolerance treatment under term agreement october nbsp selecta jdrf announced another collaboration with sanofi research novel antigen specific immune therapy type diabetes font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold about celiac disease font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size celiac disease gluten induced chronic inflammatory disorder small bowel affecting approximately population europe causing wide range symptom including diarrhea abdominal pain weight loss hypoproteinemia severe form disease lead small intestinal adenocarcinoma gluten free diet only available treatment option ineffective approximately patient compliance impairs quality life affected patient program celiac disease aimed rebalancing immune response specifically gluten without affecting other function immune system font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold about selecta font style margin font size face time roman style font size nbsp font style font size margin font size face time roman style font size selecta bioscience nbsp font clinical stage biotechnology company developing novel drug that immune modulating nanomedicines generate targeted antigen specific immune response prevent treat disease selecta proprietary synthetic vaccine particle platform creates novel paradigm immunotherapeutics vaccine enabling completely application while offering potential improved efficacy safety profile style margin font size face time roman style font size nbsp font style margin font size face time roman style font size selecta immunomodulatory svps induce antigen specific immune tolerance enabling them applied variety therapeutic area with large unmet medical need company focused three near term application inhibition immunogenicity biologic therapy treatment allergy treatment autoimmune disease immumogenicity adversely affect safety efficacy profile many biological therapy known have caused termination number promising biological therapy clinical development selecta product engine that potential unlock full therapeutic value biologic therapy font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size through proprietary product collaboration with leading pharmaceutical company research organization selecta building pipeline product candidate address unmet medical need serious chronic disease selecta bioscience nbsp based watertown massachusetts more information please visit selectabio font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold selecta medium font style margin font size face time roman style font size kathryn morris font style margin font size face time roman style font size yates network font style margin font size face time roman style font size font style margin font size face time roman style font size kathryn theyatesnetwork font style margin font size face time roman style font size nbsp font style margin size width noshade align left style color selecta biosiences folio file disk _zcv user hyung clear style page break before always style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold selecta investor font style margin font size face time roman style font size stephanie ascher font style margin font size face time roman style font size stern investor relation nbsp font style margin font size face time roman style font size font style margin font size face time roman style font size stephanie sternir font style margin font size face time roman style font size nbsp font style margin size width noshade align left style color selecta biosiences folio file disk _zcv user hyung tocexistflag body html text document